BETASERC

Welcome to the Brand page for “BETASERC”, which is offered here for Drug for the treatment of circulatory disorders and peripheral vascular disease, and for improving microcirculation;.

Its status is currently believed to be active. Its class is unavailable. “BETASERC” is believed to be currently owned by “Unimed, Inc.”

Owner:
UNIMED, INC.
Owner Details
Description:
DRUG FOR THE TREATMENT OF CIRCULATORY DISORDERS AND PERIPHERAL VASCULAR DISEASE, AND FOR IMPROVING MICROCIRCULATION;
Categories: DRUG FOR TREATMENT